[1]. Comparing oncological outcomes and safety between photodynamic diagnosis-assisted and white-light transurethral resection in elderly patients with non-muscle invasive bladder cancer.
Japanese journal of clinical oncology （2025年） [査読] 有
[DOI] [2]. Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.
International journal of urology : official journal of the Japanese Urological Association [巻]31 [号]5 [頁]526 -533 （2024年） [査読] 有
[3]. Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.
Japanese journal of clinical oncology [巻]52 [号]8 [頁]944 -949 （2022年） [査読] 有
[DOI] [4]. A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2'-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients.
Genes and environment : the official journal of the Japanese Environmental Mutagen Society [巻]43 [号]1 [頁]52 （2021年） [査読] 有
[DOI] [5]. Kidney transplantation from a living donor with renal artery fibromuscular dysplasia: A case report on arterial grafting of the donor renal artery.
IJU case reports [巻]3 [号]5 [頁]201 -203 （2020年） [査読] 有
[DOI]